Group 1 - The core viewpoint is that 麦克奥迪实业集团有限公司 has obtained a patent for an "Electric Turntable and Optical Microscope," which is significant in the field of optical imaging technology [1] - The patent includes components such as a base, turntable, motor, gears, magnets, and sensors, indicating a complex design aimed at enhancing optical imaging capabilities [1] - The application date for the patent is November 2024, suggesting future developments in the company's product offerings [1] Group 2 - 麦克奥迪实业集团有限公司 was established in 1995 and is located in Xiamen, primarily engaged in the manufacturing of instruments and meters [2] - The company has a registered capital of 172.1941 million RMB and has made investments in 13 enterprises, indicating a diversified business strategy [2] - 麦克奥迪 has participated in 626 bidding projects and holds 378 patents, showcasing its active role in innovation and market competition [2]

Group 1 - Weisheng Information won four projects in August with a total amount of 85.5377 million yuan, accounting for 3.12% of the company's total revenue for 2024 [1] - Longqi Technology's shareholder plans to reduce its stake by up to 4.09%, equating to a maximum of 19.1916 million shares [1] - Guojin Modern's subsidiary received a drug registration certificate for injectable Nicardipine, used for treating unstable angina [3][4] Group 2 - SAIC Motor reported a total vehicle sales of 363,400 units in August, a year-on-year increase of 41.04%, with new energy vehicle sales reaching 129,800 units, up 49.89% [5] - Kuka Home plans to invest 1.124 billion yuan to build a self-owned base in Indonesia, aiming to enhance its international strategy [6] - Samsung Medical's subsidiary signed a contract for an intelligent meter project in Egypt worth 58.8 million USD, approximately 419 million yuan [8] Group 3 - North Vehicle Blue Valley's subsidiary reported a total production of 10,587 units in August, a year-on-year decrease of 15.13%, while sales increased by 3.47% [12] - Xianghe Industrial signed contracts worth 400 million yuan for railway fastener system components [13] - Hengrui Medicine's HRS9531 injection has received acceptance for its marketing authorization application [14] Group 4 - Hualu Hengsheng resumed normal production after completing maintenance on production facilities [16] - Shanghai Pharmaceuticals' hydrochloride verapamil injection passed the consistency evaluation for generic drugs [18] - Shanghai Construction received approval for debt financing tools with a registration period of two years [20] Group 5 - Kangli Elevator terminated the sale of its wholly-owned subsidiary due to the buyer's failure to obtain necessary approvals [21] - Times Wan Heng appointed Li Zhizhong as the new deputy general manager [22] - Hanma Technology reported a total truck sales of 1,051 units in August, a year-on-year increase of 58.05% [24] Group 6 - Wenzhou Hongfeng's subsidiary received a utility model patent certificate for a servo adjustment device [26] - Yibin Technology received a project designation from a domestic new energy vehicle company, with an estimated total sales of 243 million yuan over five years [28] - Star Ring Technology's H-share issuance application was accepted by the China Securities Regulatory Commission [30] Group 7 - Microchip Bio's vice president resigned for personal reasons [31] - Zhongxin Co. announced the resignation of a non-independent director due to personal reasons [32] - Changcheng Military Industry's vice chairman resigned due to retirement [35] Group 8 - Jiukang Bio received four invention patent certificates related to detection reagents [36] - Meino Bio's subsidiary changed its registered address [37] - Kuangda Technology announced a potential change in control due to a share transfer [38] Group 9 - China Rare Earth confirmed no undisclosed significant matters amid stock price fluctuations [72]

Mergers and Acquisitions - Huahong Company plans to acquire 97.5% equity of Huali Microelectronics through a combination of issuing shares and cash payment, raising supporting funds [1] - Olin Bio intends to acquire 15% equity of Xinnuo Ming Bio from minority shareholders via public transfer at a price not exceeding 45 million yuan [2] - Dongxin Co. plans to invest approximately 211 million yuan in Shanghai Lishuan, holding about 35.87% equity post-investment [3] Shareholding Changes - Gao Neng Environment's controlling shareholder plans to reduce holdings by up to 3%, equating to a maximum cash-out of 320 million yuan [4][5] - Hu Dian Co.'s senior management intends to reduce holdings by up to 16,040 shares, representing about 0.0083% of total equity [6] - Maike Audi's shareholders have collectively reduced their holdings by 2.17%, with specific reductions of 5.41 million shares and 5.86 million shares [7] Risk Matters - *ST Tianmao plans to voluntarily withdraw its A-share listing and will initiate a protection mechanism for dissenting shareholders [8] - China Rare Earth confirms no undisclosed matters that could affect stock trading prices amid unusual trading fluctuations [9] Lock-up Release - Suda Co. announces that approximately 27.94 million shares will be released from lock-up on September 3, 2025, accounting for 36.76% of total equity [10]

每经记者｜王琳 每经编辑｜张海妮 并购重组 华虹公司：拟购买华力微97.5%股权 华虹公司公告，公司拟以发行股份及支付现金的方式，向上海华虹（集团）有限公司、上海集成电路产 业投资基金股份有限公司、国家集成电路产业投资基金二期股份有限公司、上海国投先导集成电路私募 投资基金合伙企业（有限合伙）购买其持有的上海华力微电子有限公司97.5%股权并募集配套资金。公 司股票将于2025年9月1日开市起复牌。 欧林生物：拟收购新诺明生物15%股权 欧林生物公告，公司控股子公司新诺明生物的少数股权股东一号基金以及菁创基金拟通过西南联合产权 交易所公开转让方式转让其合计持有的新诺明生物15%股权。公司拟以不超过标的股权挂牌底价上浮 5%且不超过4500万元的资金参与竞购。 东芯股份：拟以约2.11亿元增资上海砺算 东芯股份公告，公司拟与亨通集团有限公司、上海道禾长期投资管理有限公司管理的基金、其他投资主 体、上海砺算员工持股平台共同对外投资上海砺算，投资人合计投资金额约为5亿元。其中，公司拟以 约2.11亿元向上海砺算增资，本次增资完成后，公司将持有上海砺算约35.87%的股权。 增减持 高能环境：控股股东拟减持不超过3% ...

Group 1 - The company McAudie announced a share reduction plan by its shareholders, McAudie Holdings Ltd. and Hong Kong Xielihang Ltd., intending to sell approximately 1,242 million shares each, representing 2.4% of the total share capital within three months after the announcement [1] - McAudie Holdings Ltd. has already reduced approximately 541 million shares, accounting for 1.04% of its holdings, while Hong Kong Xielihang Ltd. has reduced about 586 million shares, representing 1.13% of its holdings [1] Group 2 - For the first half of 2025, McAudie's revenue composition is as follows: 60.06% from power distribution and transmission equipment manufacturing, 25.64% from microscope manufacturing, and 14.3% from medical equipment and instrument manufacturing [2] Group 3 - As of the latest report, McAudie's market capitalization stands at 9.1 billion yuan [3]

Core Viewpoint - The announcement details the share reduction plans of major shareholders of MacAudie (Xiamen) Electric Co., Ltd., including the completion of these reductions and subsequent regulatory actions taken by the China Securities Regulatory Commission [1][2]. Shareholder Reduction Situation - Shareholder MacAudie Holdings Limited plans to reduce its holdings by approximately 9.39% of the total share capital through block trading or centralized bidding within three months from the announcement date [1]. - Shareholder Hong Kong Xie Li Hang Limited plans to reduce its holdings by approximately 1.13% of the total share capital during a specified period [1]. - After the reductions, MacAudie Holdings Limited will hold 73,985,522 shares (14.30% of total share capital), while Hong Kong Xie Li Hang Limited will hold 42,721,398 shares (8.26% of total share capital) [1]. Regulatory Actions and Remediation - MacAudie Holdings Limited received a regulatory decision from the Xiamen Securities Regulatory Bureau, which mandated the repurchase of shares that were improperly reduced and required the payment of price differences [2]. - The company has since repurchased the improperly reduced shares at a price higher than the average price of the illegal reductions, resulting in no need to pay any price difference to the company [2]. Other Relevant Information - Neither MacAudie Holdings Limited nor Hong Kong Xie Li Hang Limited is classified as a controlling shareholder or actual controller of the company, ensuring that there will be no change in control or impact on the company's ongoing operations [2].

本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 麦克奥迪（厦门）电气股份有限公司（以下简称"公司"）于近日收到股东 麦克奥迪控股有限公司出具的《简式权益变动报告书》。麦克奥迪控股有限公司 通过国信证券（香港）资产管理有限公司专户以集中竞价交易方式增持公司无限 售条件流通股 3,626,100 股。本次权益变动后，麦克奥迪控股有限公司持有公司 股份 77,611,622 股，合计占公司总股本的比例为 15.00%。 一、本次权益变动基本情况 信息披露义务人 麦克奥迪控股有限公司 权益变动时间 2025 年 8 月 28 日 股票简称 麦克奥迪 股票代码 300341 变动类型（可多 增加 减少□ 一致行动人 有 无□ 选） 是否为第一大股东或实际控制人 是□ 否 股份种类 增持股数（股） 增持比例（%） A股 3,626,100 0.70 合计 3,626,100 0.70 本次权益变动方 通过证券交易所的集中交易 协议转让□ 式（可多选） 通过证券交易所的大宗交易□ 间接方式转让□ 国有股行政划转或变更□ 执行法院裁定□ 取得上市公司发行的新股□ 继承□ 赠与□ 表决权让渡□ 其他□（请 ...

麦克奥迪（厦门）电气股份有限公司 上市公司：麦克奥迪（厦门）电气股份有限公司 股票简称：麦克奥迪 股票代码：300341 上市地点：深圳证券交易所 信息披露义务人：麦克奥迪控股有限公司 权益变动性质：增加 签署日期：2025 年 8 月 29 日 麦克奥迪（厦门）电气股份有限公司简式权益变动报告书 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国公司法》（以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）、《上市公司收购管理办法》 （以下简称《收购管理办法》）、《公开发行证券的公司信息披露内容与格式准 则第15号——权益变动报告书》（以下简称《准则15号》）、《证券期货法律 适用意见第19号—— <上市公司收购管理办法> 第十三条、第十四条的适用意见》 及其他相关的法律法规和规范性文件编制。 二、依据《中华人民共和国证券法》、《上市公司收购管理办法》和《公开 发行证券的公司信息披露内容与格式准则第15号—权益变动报告书》的规定，本 报告书已全面披露信息披露义务人在麦克奥迪（厦门）电气股份有限公司（以下 简称"麦克奥迪"）拥有权益的股份。截至本报告书签署之日，除本报告书披露 的持股 ...

每经AI快讯，8月31日，麦克奥迪公告，麦克奥迪控股有限公司通过集中竞价交易方式增持麦克奥迪 362.61万股无限售条件流通股。本次权益变动后，信息披露义务人持有麦克奥迪股份7761.1622万股，占 总股本的15.00%。本次变动不会导致公司第一大股东、控股股东、实际控制人及其一致行动人发生变 化，不会对公司治理结构及持续经营产生重大影响。未来12个月内，信息披露义务人无增持计划，但可 能根据实际情况减持股份。 登录新浪财经APP 搜索【信披】查看更多考评等级 ...

麦克奥迪（厦门）电气股份有限公司 关于持股5%以上股东权益变动触及5%整数倍的提示性公告 证券代码：300341 证券简称：麦克奥迪 公告编号：2025-036 本公司持股5%以上的股东麦克奥迪控股有限公司保证向本公司 提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 1、本次权益变动主体为持有公司 5%以上股份股东麦克奥迪控股有限公司， 不属于公司第一大股东、控股股东、实际控制人及其一致行动人，本次权益变动 不会导致公司第一大股东、控股股东、实际控制人及其一致行动人发生变化，不 会对公司治理结构及持续经营产生重大影响。 2、本次权益变动方式为集中竞价增持，不触及要约收购。 2 三、备查文件 1、股东出具的《简式权益变动报告书》； 2、深交所要求的其他文件。 麦克奥迪（厦门）电气股份有限公司（以下简称"公司"）于近日收到股东 麦克奥迪控股有限公司出具的《简式权益变动报告书》。麦克奥迪控股有限公司 通过国信证券（香港）资产管理有限公司专户以集中竞价交易方式增持公司无限 售条件流通股 3,626,100 股。本次权益变动后 ...